Glioblastoma tumor stem cells (CSCs) have large amounts of its receptor, PTPRZ1, which activate a series of signaling pathways that produce CSCs and maintain their malignant behavior, promoting tumor growth and progression and leading to increased mortality in patients (Shi et al., 2017). The gene discussed is PTPRZ1; the disease is glioblastoma.